结构修改将肝毒性塔克林转化为新的肝保护性类似物
Amani A Sorour1, Rania G Aly2, Hanan M Ragab3
1Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
ACS omega
|January 22, 2024
概括
新的塔克林类比衍生物显示出显著的肝保护作用,防止肝损伤. 这些化合物作为抗氧化剂,抗炎剂和抗纤维素剂,为肝纤维化提供潜在的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 药用化学 医学化学
背景情况:
- 肝脏执行重要功能,但肝纤维化缺乏有效的治疗方法.
- 塔克林类同类药物被开发用于降低肝毒性,但它们在肝损伤中的治疗潜力仍然未被探索.
研究的目的:
- 为了研究化和非化4-四基诺林衍生物的肝保护潜力.
- 在肝损伤模型中评估这些新型化合物的抗氧化,抗炎和抗纤维作用.
主要方法:
- 在化学诱导的肝损伤模型中,使用4-四氨基氨基胺衍生物.
- 评估肝脏指标,抗氧化酶活性,炎症标志物 (TNF-α,IL-6),亡蛋白 (Bax,Bcl2) 和纤维基因介质 (α-SMA,TGF-β).
- 组织病理学分析和计算机辅助的分子对接模拟.
主要成果:
- 四基诺林衍生物显示出显著的肝保护作用,防止化学诱导的肝损伤.
- 化合物使抗氧化酶活动正常化,并调节炎症,亡和纤维素标志物.
- 组织病理学和分子对接支持观察到的体内肝脏保护活性.
结论:
- 设计的塔克林类似物在急性肝损伤中表现出有希望的肝保护作用.
- 观察到的好处归因于化合物的抗氧化,抗炎和抗纤维素性质.
- 这些衍生品代表肝纤维化和相关疾病的潜在治疗剂.
相关概念视频
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
62
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
62
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K